Benign Conditions

Benign Prostatic Hyperplasia

Bladder Cancer

Female Urology

Genitourinary Cancers

Genomic Testing

Hormone Therapy

Kidney Cancer

Kidney Stones

Men's Health

Next-Generation Imaging

OAB and Incontinence

Pediatrics

Prostate Cancer

Sexual Dysfunction

UTUC

Urologic Surgery

Business

Practice Management

Malpractice Consult

Health Law & Policy

Clinical

All Clinical

Media

Case-Based Peer Perspectives

Medical World News

Podcasts

Rapid Readouts

Urology Medical Perspectives

UTv Videos

UroView

Viewpoints

Virtual Tumor Board

Conferences

Conference Listing

Conference Previews 

Conference Recaps

Publications

Urology Times Journal

Editorial Advisory Board

Urologists in Cancer Care

Supplements and Featured Publications

Events

Live Events

Virtual Events

CME/CE

Resources

Interactive Tools

Job Board

Partners

Subscribe

Print Subscription

eNewsletter

Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.

About Us

Advertise

Contact Us

Terms and Conditions

Privacy

Do not sell my Personnal Information

Urology Times | News & Insights for Urologists & Health Professionals

Facebook

Twitter

LinkedIn

Spotlight

GU Cancers Symposium

1rem

Clinical Focus

Articles

The study compared the 2 procedures over 24 months of follow-up.

HoLEP may provide more durable benefit than PVP in patients with BPH 

Significant improvements in BPH-related lower urinary tract symptoms were observed with the system.

BPH catheter system shows encouraging outcomes in pilot trial

Steven A. Kaplan, MD, explains the updates in the AUA 2020 guideline on lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Panel expert details changes to AUA BPH guideline

Only 1.5% of patients undergo repeat surgical intervention for BPH recurrence.

Photoselective vaporization of the prostate found safe, durably effective

Patient-reported outcomes showed a superior experience regarding post-procedure BPH symptoms with the UroLift prostatic urethral lift over Rezum tissue ablation with steam injection.


PROs favor prostatic urethral lift over water vapor ablation for BPH symptoms

® Assistant Editor Janelle Hart spoke with 

 He discusses the stigmas associated with enlargement of the prostate, or benign prostatic hyperplasia, and why more education is necessary to absolve these misconceptions. McVary is a professor of urology at the Stritch School of Medicine and director of the Center for Male Health at the Loyola University Medical Center in Maywood, Illinois.

“Even though there [are] many therapies that one can do, it's not a sign of anything ominous for most men,” says Kevin T. McVary, MD, FACS.

Destigmatizing Urology: Dr. McVary discusses enlarged prostates

paper, New Endoscopic In-office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review, for which he served as senior author. Lee is an Associate Professor of Urology and Healthcare Policy & Research at Weill Cornell Medicine Department of Urology in New York City.

The study encompassed the prostatic urethral lift (UroLift), water vapor thermal therapy (Rezum), and temporary implantable nitinol device (iTIND).

Study: New BPH treatments demonstrate efficacy

The investigators retrospectively analyzed ABU case log data on 8 different BPH surgical procedures ranging from 2008 to 2021. 

Current BPH practice patterns influenced by surgeon factors

“This study shows prostate artery embolization to be a safe and highly effective treatment whose long-term outcomes include sustained LUTS relief, significant improvement in quality of life and no change in erectile function,” according to Shivank Bhatia, MD. 

Study highlights efficacy of prostate artery embolization in BPH

“Improved quality of life is the key benefit for our BPH patients," says Scott Barkin, DO.

Central Ohio Urology Group among first in region to offer Aquablation therapy for BPH

The new payment rate goes into effect January 2023 and will expand access to care for Medicare beneficiaries.

CMS final rule increases payment rate for iTind procedure in HOPD and ASC

As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia.

Videos

“For practicing urologists, I think it's important for us to recognize that when it comes to these techniques, even with Rezum, there's a variety of ways of doing them," says Bilal Chughtai, MD.

Dr. Chughtai explains how "less is more" approach has implications for BPH

Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, 

discusses the importance of the new wave of minimally invasive BPH treatments for both patients and clinicians. Gill is a urologist with Glickman Urological & Kidney Institute at Cleveland Clinic.

“It’s pretty clear that over the past 50 years we've seen innovations in BPH treatment both from the utilization of technology and also from the patient outcome and experience standpoint,” says Bradley Gill, MD, MS.

Innovation Celebration

Dr. Gill explains the importance of BPH treatment innovations to urology 

, an associate professor of Urology at Weill Cornell Medical College, discusses the background and findings of his recent paper, "Pilot study of ‘less is more’ Rezum for treatment of BPH."

“We found that the adverse event rates have dropped dramatically, to about a third of what it was reported in the pivotal trial, but at the same time still had the same net benefits in terms of efficacy when it comes to Q max, symptomatic improvement, as well as PVR," said Bilal Chughtai, MD. 

Interviews

Dr. Chughtai discusses new pilot study on Rezum treatment for BPH

, chief of the Division of Endourology and Stone Disease and professor of Urology at Northwestern Medicine, is a world leader in holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia (BPH). 

In this video, Dr. Krambeck takes the viewer step by step through the HoLEP procedure in the OR on a patient with an extremely large prostate (158g) who presented with severe overactive bladder, obstructive voiding symptoms, and urinary incontinence and retention.

Watch Amy E. Krambeck, MD, perform holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. 

NOFOLLOW

NOINDEX

Video: Dr. Amy Krambeck performs HoLEP

Bilal Chughtai, MD, an associate professor of Urology at Weill Cornell Medical College, discusses ongoing research with saw palmetto extract for patients with benign prostatic hyperplasia and lower urinary tract symptoms. Chughtai was part of an international panel of leading urologists from North America and Europe who published the 

, “Rethinking the Role of Saw Palmetto Extract for Men with Lower Urinary Tract Symptoms in North America.”

“We’re in the process of following patients who have taken saw palmetto extract and tracking their clinical diagnosis,” says Bilal Chughtai, MD.

Dr. Chughtai on next research steps with saw palmetto extract for BPH/LUTS

Bilal Chughtai, MD, an associate professor of Urology at Weill Cornell Medical College, explains why he believes it is an “exciting time” for extracts, such as saw palmetto, for the treatment of patients with benign prostatic hyperplasia and lower urinary tract symptoms. Chughtai was part of an international panel of leading urologists from North America and Europe who published the 

, “Rethinking the Role of Saw Palmetto Extract for Men with Lower Urinary Tract Symptoms in North America.” In the conclusion of the paper, Chughtai and colleagues wrote that after reviewing the evidence they recommend that saw palmetto extract “be considered as a treatment option for men with mild-to-moderate BPH/LUTS as an alternative to watchful waiting.”

Chughtai was part of an international panel of leading urologists from North America and Europe who published the consensus paper, “Rethinking the Role of Saw Palmetto Extract for Men with Lower Urinary Tract Symptoms in North America."

Dr. Chughtai on why it’s “exciting time" for extracts for BPH and LUTS

 discusses what sets her HoLEP practice for treating patients with benign prostatic hyperplasia from other centers. Miller is a professor of urology and fellowship director, Endourology and Laparoscopic Surgery, at Vanderbilt University Medical Center in Nashville, Tennessee.

“We're doing probably one of the highest volume of HoLEP cases…in the United States,” says Nicole L. Miller, MD, FACS.

Dr. Miller: “No limits” to what HoLEP can offer appropriate patients with BPH

 describes her clinical practice treating patients with complex benign prostatic hyperplasia. Miller is a professor of urology and fellowship director, Endourology and Laparoscopic Surgery, at Vanderbilt University Medical Center in Nashville, Tennessee.

“I think that there's certainly recognition that HoLEP is a procedure that can be self-taught and learned. But I think the learning curve is significantly shortened if you're mentored and certainly if you're fellowship trained,” says Nicole L. Miller, MD, FACS.

Dr. Nicole Miller discusses her BPH practice

® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, 

 discusses the development of multichannel urodynamics testing. Goldman is a professor of urology and vice chair of the Glickman Urologic Institute at Cleveland Clinic.

“What made [multichannel urodynamics] so important is you're able to diagnose things much better; you're able to have a much better understanding of what's actually going on,” says Howard B. Goldman, MD, FACS.

Urology Times 50 Innovations Series: Multichannel urodynamics

 discusses the background and notable findings from the study, Outcomes after holmium laser enucleation of the prostate, open simple prostatectomy, and robotic simple prostatectomy: experience from a large academic medical center, which was presented at the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana. Lee is an endourology fellow at Northwestern University Feinberg School of Medicine in Chicago, Illinois.

The study evaluated holmium laser enucleation of the prostate, open simple prostatectomy, and robotic simple prostatectomy.

Benign Prostatic Hyperplasia

More News